Document Detail

A 25-year control of idiopathic ventricular fibrillation with electrophysiologic-guided antiarrhythmic drug therapy.
MedLine Citation:
PMID:  15851183     Owner:  NLM     Status:  MEDLINE    
The case of a 28-year-old man with recurrent syncope and multiple documented episodes of idiopathic ventricular fibrillation is reported. Recurrent syncope suggesting a self-terminating ventricular tachyarrhythmia occurred after 1 month of amiodarone therapy, and ventricular fibrillation was inducible at electrophysiologic study. After addition of quinidine, no significant ventricular arrhythmias could be induced. Similar results were found during a repeat electrophysiologic study performed 23.5 years later. During a 25-year period, the patient has remained arrhythmia-free on combined antiarrhythmic medication with quinidine and amiodarone.
Bernard Belhassen
Related Documents :
22822323 - Fish oil in cardiovascular prevention.
16390313 - Therapies for ventricular cardiac arrhythmias.
15861353 - Sleep apnea, coronary artery disease, and antioxidant status in hemodialysis patients.
Publication Detail:
Type:  Case Reports; Journal Article    
Journal Detail:
Title:  Heart rhythm : the official journal of the Heart Rhythm Society     Volume:  1     ISSN:  1547-5271     ISO Abbreviation:  Heart Rhythm     Publication Date:  2004 Sep 
Date Detail:
Created Date:  2005-04-26     Completed Date:  2005-06-28     Revised Date:  2009-10-27    
Medline Journal Info:
Nlm Unique ID:  101200317     Medline TA:  Heart Rhythm     Country:  United States    
Other Details:
Languages:  eng     Pagination:  352-4     Citation Subset:  IM    
Department of Cardiology, Tel-Aviv Sourasky Medical Center, and Sackler School of Medicine, Tel-Aviv University, Tel-Aviv, Israel.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Amiodarone / administration & dosage*
Anti-Arrhythmia Agents / administration & dosage*
Drug Therapy, Combination
Follow-Up Studies
Quinidine / administration & dosage*
Time Factors
Treatment Outcome
Ventricular Fibrillation / drug therapy*,  physiopathology
Reg. No./Substance:
0/Anti-Arrhythmia Agents; 1951-25-3/Amiodarone; 56-54-2/Quinidine

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Recurrent ventricular fibrillation secondary to aortic valve tumor.
Next Document:  Cardiac resynchronization therapy in congestive heart failure: Ready for prime time?